Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-&kgr;B

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Critical Care Medicine

• Publication date

  2002-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00003246-200205001-00019PMID 12004250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Disseminated intravascular coagulation].

  2003cited by this paper
• The protein C pathway.

  2003cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001influential reference
• Disseminated intravascular coagulation in severe sepsis patients treated with recombinant human Activated Protein C, a retrospective subgroup analysis from the PROWESS trial

  2001cited by this paper
• Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis*

  2001influential reference
• Effect of corticosteroids on nuclear factor-&kgr;B activation and hemodynamics in late septic shock

  2001cited by this paper
• Anti-Inflammatory, Antithrombotic, and Neuroprotective Effects of Activated Protein C in a Murine Model of Focal Ischemic Stroke

  2001cited by this paper
• Activated Protein C Prevents Endotoxin-Induced Hypotension in Rats by Inhibiting Excessive Production of Nitric Oxide

  2001cited by this paper
• Possible new role for NF-kappaB in the resolution of inflammation.

  2001cited by this paper
• Possible new role for NF-κB in the resolution of inflammation

  2001cited by this paper
• Activated protein C and inflammation in human myocardium after heart surgery

  2001cited by this paper
• Protease-activated Receptors in Vascular Biology

  2001cited by this paper
• Role of Coagulation Inhibitors in Inflammation

  2001cited by this paper
• Recombinant human activated protein C: A system modulator of vascular function for treatment of severe sepsis

  2001cited by this paper
• Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation.

  2000cited by this paper
• Direct Transactivation of the Anti-apoptotic Gene Apolipoprotein J (Clusterin) by B-MYB*

  2000cited by this paper
• Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.

  2000cited by this paper
• Changes in Endoplasmic Reticulum Luminal Environment Affect Cell Sensitivity to Apoptosis

  2000cited by this paper
• NF-κB activation

  2000cited by this paper
• Activated protein C inhibits lipopolysaccharide‐induced nuclear translocation of nuclear factor κB (NF‐κB) and tumour necrosis factor α (TNF‐α) production in the THP‐1 monocytic cell line

  2000cited by this paper
• Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation

  2000cited by this paper
• Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?

  2000cited by this paper
• NF-kappaB activation.

  2000cited by this paper
• The protein C pathway

  2000cited by this paper
• Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes.

  2000cited by this paper
• Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework

  2000cited by this paper
• Apoptosis in sepsis.

  2000cited by this paper
• Protein C may be sepsis solution

  2000cited by this paper
• Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease?

  2000cited by this paper
• The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis.

  2000cited by this paper
• Treating patients with severe sepsis.

  1999cited by this paper
• Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion.

  1999cited by this paper
• Disseminated Intravascular Coagulation

  1999cited by this paper
• Inflammation, sepsis, and coagulation.

  1999cited by this paper
• Treating patients with severe sepsis.

  1999cited by this paper
• Human Endothelium as a Source of Multifunctional Cytokines: Molecular Regulation and Possible Role in Human Disease

  1999cited by this paper
• Novel antithrombotics based on modulation of the protein C pathway.

  1998cited by this paper
• Has the mortality of septic shock changed with time.

  1998cited by this paper
• Sol Sherry lecture in thrombosis: how thrombin 'talks' to cells: molecular mechanisms and roles in vivo.

  1998cited by this paper
• The sirens' songs of confirmatory sepsis trials: selection bias and sampling error.

  1998cited by this paper
• Endothelial Cells: Role in Infection and Inflammation

  1998cited by this paper
• Septic shock.

  1998cited by this paper
• Novel antithrombotics based on modulation of the protein C pathway.

  1998cited by this paper
• Role of the Coagulation System in the Local and Systemic Inflammatory Response

  1998cited by this paper
• The role of the endothelium in changes in procoagulant activity in sepsis.

  1998cited by this paper
• Apoptotic vascular endothelial cells become procoagulant.

  1997cited by this paper
• Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.

  1997cited by this paper
• Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

  1997cited by this paper
• Functional interactions between the thrombin receptor and the T-cell antigen receptor in human T-cell lines.

  1997cited by this paper
• Epidemiology of sepsis syndrome in 8 academic medical centers.

  1997cited by this paper
• Therapies for sepsis. Emerging therapies for sepsis and septic shock.

  1997cited by this paper
• Immunobiology and therapeutic applications of protein c/protein s/thrombomodulin in human and experimental allotransplantation and xenotransplantation.

  1997cited by this paper
• ALTERATIONS IN COAGULATION AND FIBRINOLYSIS DURING SEPSIS

  1996cited by this paper
• Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.

  1996cited by this paper
• Molecular Cloning and Expression of Murine and Bovine Endothelial Cell Protein C/Activated Protein C Receptor (EPCR)

  1995cited by this paper
• Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

  1995cited by this paper
• Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units

  1995cited by this paper
• Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses.

  1995cited by this paper
• Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.

  1994cited by this paper
• Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor.

  1994cited by this paper
• Recombinant human protein C, protein S and thrombomodulin as antithrombotics

  1994cited by this paper
• Chapter 11. Antithrombotic and Anti-Inflammatory Agents of The Protein C Anticoagulant Pathway

  1994cited by this paper
• Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide.

  1994cited by this paper
• Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-gamma, or PMA: modulation of effects on CD11b and CD14 but not CD25 or CD54 induction.

  1993cited by this paper
• The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy.

  1992cited by this paper
• Characterization of a functional thrombin receptor. Issues and opportunities.

  1992cited by this paper
• The pathogenesis of sepsis.

  1991cited by this paper
• DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.

  1991cited by this paper
• Plasma thrombomodulin in health and diseases.

  1990cited by this paper
• Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture.

  1989cited by this paper
• Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells

  1988cited by this paper
• Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

  1987cited by this paper
• SEPTIC SHOCK

  1964cited by this paper

• Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K

  2025cites this paper
• Protein C in adult patients with sepsis: from pathophysiology to monitoring and supplementation

  2025cites this paper
• Prospective Application of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Disseminated Intravascular Coagulation

  2024cites this paper
• The immunomodulatory effects of vitamins in cancer

  2024cites this paper
• Vitamin K Contribution to DNA Damage—Advantage or Disadvantage? A Human Health Response

  2022cites this paper
• Protein C Pathway in Paediatric and Neonatal Sepsis

  2022cites this paper
• The Anti-Inflammatory Effect of Nanoarchaeosomes on Human Endothelial Cells

  2022cites this paper
• The protein C pathways

  2022cites this paper
• Signaling pathways and intervention therapies in sepsis

  2021cites this paper
• Soluble recombinant human thrombomodulin suppresses inflammation-induced gastrointestinal tumor growth in a murine peritonitis model

  2020cites this paper
• Gly197Arg mutation in protein C causes recurrent thrombosis in a heterozygous carrier

  2020cites this paper
• Is tri-iodothyronine a better choice than activated protein C in sepsis treatment?

  2019cites this paper
• Mesenchymal stromal cells-derived matrix Gla protein contribute to the alleviation of experimental colitis

  2018cites this paper
• The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation

  2018cites this paper
• Activated protein C suppresses osteoclast differentiation via endothelial protein C receptor, protease-activated receptor-1, sphingosine 1-phosphate receptor, and apolipoprotein E receptor 2.

  2018cites this paper
• Functional Aspects of Activated Protein C (APC) in Regulating Homeostasis and Disease

  2017cites this paper
• Coagulation and Fibrinolysis Gly 74 Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function

  2017cites this paper
• Protease-Activated Receptor-1 Supports Locomotor Recovery by Biased Agonist Activated Protein C after Contusive Spinal Cord Injury

  2017cites this paper
• Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function

  2017cites this paper
• Effect of thrombin and other PAR1 agonists on endothelium. Role of AMP-kinase and biased signaling.

  2017cites this paper
• Einfluss von doppelsträngiger RNA auf die Thrombusbildung in der Mikrozirkulation der Maus

  2016influential citation
• Pediatric Musculoskeletal Infection: Hijacking the Acute-Phase Response

  2016cites this paper
• Adeno-Associated Viral Vector-Driven Expression of Coagulation Proteins for Treatment of Hemophilias and Cancer

  2015cites this paper
• Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis

  2015cites this paper
• &bgr;1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock*

  2015cites this paper
• The Interaction Between Pathogens and the Host

  2015cites this paper
• The Role of Activated Protein C in Bone, Arthritis, and Fracture Healing

  2015cites this paper
• Activated Protein C Ameliorates Renal Ischemia-Reperfusion Injury by Restricting Y-Box Binding Protein-1 Ubiquitination.

  2015cites this paper
• Protective effects of activated protein C on neurovascular unit in a rat model of intrauterine infection-induced neonatal white matter injury

  2015cites this paper
• Activated protein C: A regulator of human skin epidermal keratinocyte function.

  2014cites this paper
• Effect of arazyme on the lipopolysaccharide‑induced inflammatory response in human endothelial cells.

  2014cites this paper
• Activated protein C and its potential applications in prevention of islet β-cell damage and diabetes.

  2014cites this paper
• SUPPRESSION OF MALIGNANT MESOTHELIOMA BY OVEREXPRESSION OR STIMULATION OF EN DOTHELIAL PROTEIN C RECEPTORS (EPCR)

  2014cites this paper
• AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease

  2014cites this paper
• Endothelial cell protein C receptor opposes mesothelioma growth driven by tissue factor.

  2013cites this paper
• An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock.

  2013cites this paper
• Why Activated Protein C Was Not Successful in Severe Sepsis and Septic Shock: Are We Still Tilting at Windmills?

  2013cites this paper
• Targeting the host hemostatic system function in bacterial infection for antimicrobial therapies

  2013cites this paper
• Endothelial cell signalling of APC and thrombin : the involvement of protein kinase C

  2013cites this paper
• in vivo Platelet factor 4 enhances generation of activated protein C in vitro and

  2013cites this paper
• Identifying functional single nucleotide polymorphisms in two candidate genes (PROC and PCSK9) in sepsis

  2013cites this paper
• Alterations of leptin in the course of inflammation and severe sepsis

  2012cites this paper
• Activated protein C is the regulator of the NF-κB activity under the conditions of glutamate toxicity

  2012cites this paper
• An Activated Protein C Analog With Reduced Anticoagulant Activity Extends the Therapeutic Window of Tissue Plasminogen Activator for Ischemic Stroke in Rodents

  2012cites this paper
• Proteína c activada y polimorfismo genético en la sepsis grave

  2012cites this paper
• Is EPCR a multi-ligand receptor? Pros and cons

  2012cites this paper
• Ex-vivo Effekte von Gerinnungsinhibitoren auf die zelluläre Immunfunktion nach Trauma

  2012cites this paper
• The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm

  2012cites this paper
• The multiple layers of signaling selectivity at protease-activated receptors.

  2012cites this paper
• Protease‐activated receptor‐1 cleaved at R46 mediates cytoprotective effects

  2012cites this paper
• Advances in Sepsis Therapy

  2012cites this paper
• Persistent Systemic Inflammation in Chronic Critical Illness

  2012cites this paper
• Activated Protein C Has a Protective Effect against Myocardial I/R Injury by Improvement of Endothelial Function and Activation of AKT1

  2012cites this paper
• Xeno-kidney transplantation: from idea to reality.

  2012cites this paper
• Thrombomodulin: A Bifunctional Modulator of Inflammation and Coagulation in Sepsis

  2012cites this paper
• Barrier protective effects of lycopene in human endothelial cells

  2011cites this paper
• Activated protein C protects against myocardial ischemic/reperfusion injury through AMP‐activated protein kinase signaling

  2011cites this paper
• Innate immunity and coagulation

  2011cites this paper
• Effets de la protéine C activée et des glucocorticoïdes dans le choc septique expérimental

  2011cites this paper
• Cytoprotective protein C pathways and implications for stroke and neurological disorders.

  2011cites this paper
• Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

  2011cites this paper
• Protein C anticoagulant system—anti-inflammatory effects

  2011cites this paper
• Targeting Fatigue in Stroke Patients

  2011cites this paper
• Inhibitory effect of thrombin on the expression of secretory group IIA phospholipase A2

  2011cites this paper
• Tissue Factor, Blood Coagulation, and Beyond: An Overview

  2011cites this paper
• Activated protein C modulates inflammation, apoptosis and tissue factor procoagulant activity by regulating endoplasmic reticulum calcium depletion in blood monocytes

  2011cites this paper
• Do statins play a role as an adjuvant therapy in inflammation? 1

  2010cites this paper
• Activated protein C reduces intestinal injury in an experimental model of necrotizing enterocolitis.

  2010cites this paper
• Interleukin-10 gene down-expression in circulating mononuclear cells during infusion of drotrecogin-α activated: a pilot study

  2010cites this paper
• Blood coagulation as an intrinsic pathway for proinflammation: a mini review.

  2010cites this paper
• Spielen Statine eine Rolle als adjuvante Therapie bei Entzündung? / Do statins play a role as an adjuvant therapy in inflammation?

  2010cites this paper
• IL-10 gene down-expression in circulating mononuclear cells duringafter 36 h infusion of drotrecogin-α activated : a pilot study

  2010cites this paper
• Anticoagulant therapy in critical organ ischaemia/reperfusion injury

  2010cites this paper
• Entzündung und Sepsis

  2010cites this paper
• Blood coagulation disorders in septic patients

  2010cites this paper
• Thrombin and activated protein C inhibit the expression of secretory group IIA phospholipase A(2) in the TNF-alpha-activated endothelial cells by EPCR and PAR-1 dependent mechanisms.

  2010cites this paper
• Regulation of the protein C anticoagulant and antiinflammatory pathways.

  2010cites this paper
• Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges

  2010cites this paper
• What's Next? Unraveling Severe Sepsis: Why Did OPTIMIST Fail and

  2010cites this paper
• MMP‐mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids

  2010cites this paper
• Activated protein C prevents glutamate- and thrombin-induced activation of nuclear factor-kappaB in cultured hippocampal neurons.

  2010cites this paper
• Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells.

  2010cites this paper
• Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells

  2009cites this paper
• Activated Protein C Protects Against Myocardial Ischemia/ Reperfusion Injury via Inhibition of Apoptosis and Inflammation

  2009cites this paper
• The role of saliva in tick feeding.

  2009cites this paper
• Adjunctive therapies in a clinical revelant ovine model of septic shock

  2009influential citation
• Urgent care in gynaecology: resuscitation and management of sepsis and acute blood loss.

  2009cites this paper
• Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.

  2009cites this paper
• Saponin fraction from Astragalus membranaceus roots protects mice against polymicrobial sepsis induced by cecal ligation and puncture by inhibiting inflammation and upregulating protein C pathway

  2009cites this paper
• Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C.

  2009cites this paper
• Fat-Soluble Vitamins

  2009cites this paper
• Can we predict the effects of NF-κB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate

  2009cites this paper
• Activated Protein C Improves Ischemic Flap Survival and Modulates Proangiogenic and Antiinflammatory Gene Expression

  2009cites this paper
• Thrombin inhibits nuclear factor κB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C

  2009influential citation
• Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

  2009cites this paper
• Activated protein C: a promising drug with multiple effects?

  2009cites this paper
• ACTIVATED PROTEIN C CAN BE USED AS A PROPHYLACTIC AS WELL AS A THERAPEUTIC AGENT FOR HEAT STROKE IN RODENTS

  2009cites this paper
• Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications

  2008cites this paper
• Activated protein C mediates a healing phenotype in cultured tenocytes

  2008cites this paper
• Effects of pharmacological intervention on coagulopathy and organ function in xenoperfused kidneys

  2008cites this paper